Hypoxia-induced neutrophil survival is mediated by HIF-1 alpha-dependent NF-kappa B activity by Walmsley, S.R. et al.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
 
JEM © The Rockefeller University Press $8.00
Vol. 201, No. 1, January 3, 2005 105–115 www.jem.org/cgi/doi/10.1084/jem.20040624
 
ARTICLE
 
105
Hypoxia-induced neutrophil survival 
is mediated by HIF-1
 

 
–dependent 
NF-
 

 
B activity
 
Sarah R. Walmsley,
 
1
 
 Cristin Print,
 
2
 
 Neda Farahi,
 
1
 
 Carole Peyssonnaux,
 
3
 
 
Randall S. Johnson,
 
3
 
 Thorsten Cramer,
 
3
 
 Anastasia Sobolewski,
 
1 
 
Alison M. Condliffe,
 
1
 
 Andrew S. Cowburn,
 
1
 
 Nicola Johnson,
 
2
 
 
 
and Edwin R. Chilvers
 
1
 
1
 
Division of Respiratory Medicine, Department of Medicine, School of Clinical Medicine, University of Cambridge, 
Addenbrooke’s and Papworth Hospitals, Cambridge, CB2 2QQ, UK
 
2
 
Department of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK
 
3
 
Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093
 
Neutrophils are key effector cells of the innate immune response and are required to 
migrate and function within adverse microenvironmental conditions. These inflammatory 
sites are characterized by low levels of oxygen and glucose and high levels of reductive 
metabolites. A major regulator of neutrophil functional longevity is the ability of these cells 
to undergo apoptosis. We examined the mechanism by which hypoxia causes an inhibition of 
neutrophil apoptosis in human and murine neutrophils. We show that neutrophils possess 
the hypoxia-inducible factor (HIF)-1
 
 
 
and factor inhibiting HIF (FIH) hydroxylase oxygen-
sensing pathway and using HIF-1
 

 
–deficient myeloid cells demonstrate that HIF-1
 

 
 is 
directly involved in regulating neutrophil survival in hypoxia. Gene array, TaqMan PCR, 
Western blotting, and oligonucleotide binding assays identify NF-
 

 
B as a novel hypoxia-
regulated and HIF-dependent target, with inhibition of NF-
 

 
B by gliotoxin or parthenolide 
resulting in the abrogation of hypoxic survival. In addition, we identify macrophage 
inflammatory protein-1
 

 
 as a novel hypoxia-induced neutrophil survival factor.
 
As neutrophils migrate from the circulation to
sites of inflammation, they are required to
adapt to and function within oxygen tensions
much lower than those encountered in the cir-
culatory system. Moreover, the physiological
oxygen gradient that normally exists between
the alveolus and mitochondria (1) is often
greatly exaggerated in disease settings. Indeed,
in rheumatoid synovium and empyema cav-
ities, neutrophils have to function at oxygen
tensions as low as 0–3 kPa (2, 3). Although
granulocytes contain abundant mitochondria
and have the capacity for aerobic metabolism,
they rely almost exclusively on anaerobic glycol-
ysis for the generation of ATP (4). Hence,
these cells are intrinsically well adapted to oper-
ate in oxygen challenged environments. This is
of critical importance for the resolution of in-
flammation because both excessive neutrophil
activation and prolonged survival have been
implicated in a number of disease settings, in-
cluding the acute respiratory distress syndrome,
bronchiectasis, and nonresolving pneumonias.
Historically work has focused on the abil-
ity of the body to regulate O
 
2
 
 delivery to tis-
sues through hypoxic regulation of special-
ized cells within the carotid body and kidney.
However, we now recognize that oxygen sens-
ing is a more universal cellular event. This
response is mediated by the oxygen-sensitive
regulation of the 
 

 
 dimers of hypoxia-inducible
factor (HIF; references 1–3) transcriptional
complex. The regulation of HIF-
 

 
 subunits
occurs at both a protein and transcriptional
level through the action of a novel class of
prolyl and asparaginyl hydroxylase enzymes. In
the presence of oxygen, iron, and 2-oxoglu-
tarate, prolyl hydroxylase (1–3) enzymes hy-
droxylate Pro402 and 564 residues within the
oxygen-dependent domain of HIF enabling
it’s binding to von Hippel-Lindau tumor sup-
pressor protein (pVHL; references 5–8). This
initiates ubiquitination and subsequent degra-
dation; as a consequence, HIF
 

 
 is normally
maintained at very low levels under normoxic
conditions. In addition, the asparaginyl hydrox-
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ylase factor–inhibiting HIF (FIH) hydroxylates the COOH-
terminal of HIF at Asn803, thus blocking the recruitment of
the p300 coactivator needed for HIF transcriptional activity
(9–11). Therefore, reduction of hydroxylase activity by hy-
poxia results in increased protein stability and transcriptional
activity of the HIF complex, which in turn, regulates the
transcription of an array of hypoxia-responsive genes in-
cluding key glycolytic enzymes (12), erythropoietin (12),
adrenomedullin (13), SM20 (14) and VEGF (15). With re-
gard to the inflammatory response, further levels of com-
plexity have been revealed with the identification of PHD
(prolyl hydroxylase domain–containing enzyme)-dependent
HIF-independent oxygen-sensitive pathways, and the char-
acterization of distinct target gene specificities for HIF-1
 

 
and 2
 

 
 (16, 17).
The vital nature of the HIF-1
 

 
 oxygen-sensing pathway
in myeloid cell function has recently been revealed using
murine HIF-1
 

 
 conditional knockouts. In this model, the
absence of HIF-1
 

 
 in myeloid cells results in the depletion
of intracellular ATP pools and a profound impairment of
neutrophil aggregation, motility, bacterial killing, and inva-
sion (18). In vivo, this is manifest as a loss of inflammatory
response to tissue damage at pauci-vascular sites, namely the
skin and articular cartilage. This study established for the first
time the critical role for HIF-1
 

 
 in the regulation of my-
eloid cell glycolysis and its requirement for granulocytic in-
flammation, and provided a direct link between oxygen
sensing mechanisms and neutrophil activity.
A further and major regulator of neutrophil function is
the ability of these cells to undergo constitutive apoptosis
(19). This event triggers the phagocytosis and clearance of
apoptotic neutrophils by local macrophages and is vital for
the limitation of tissue damage in vivo (20, 21). Our in vitro
studies have shown that the intrinsic apoptotic thresholds in
these cells can be modified by an array of extracellular cyto-
kine and physiological environmental stimuli (19, 22) and
that the transcription factor NF-
 

 
B is critically involved
in enhancing neutrophil survival (23). We have previously
demonstrated that hypoxia causes a profound, concentra-
tion-dependent and reversible inhibition of neutrophil apop-
tosis that is not mimicked by other forms of cellular stress in-
cluding glucose deprivation or heat shock (24). Moreover,
this survival effect was inhibited by two structurally discrete
iron chelators (24) desferrioxamine (DFO) and hydroxypyri-
done. These data implicate a role for a ferroprotein in the
regulation of neutrophil apoptosis. Given the similarity of
this to the iron dependency of the hydroxylase pathway and
our demonstration of the importance of HIF in granulocyte-
mediated inflammation, we sought to establish the role of
HIF in the regulation of neutrophil apoptosis.
Here, we confirm that human peripheral blood neutro-
phils are resistant to apoptosis when cultured at reduced ox-
ygen tensions (24). Unlike the survival effect of certain cyto-
kines and growth factors, this response was phosphoinositide
3-kinase (PI3-kinase) independent, indicating involvement
of a discrete survival pathway. The hypoxic survival effect
was mimicked by the competitive inhibition of hydroxylase
enzymes and associated with marked stabilization of HIF-1
 

 
.
A direct role for HIF-1
 

 
 in the hypoxic inhibition of neu-
trophil apoptosis was provided by experiments in HIF-1
 

 
–
deficient murine neutrophils, which displayed markedly
reduced cell survival after anoxic challenge. The ability of
hypoxia to increase NF-
 

 
B p65 transcript abundance, pro-
tein expression and activity, together with the ablation of
hypoxic survival by the NF-
 

 
B inhibitors gliotoxin and par-
thenolide, and the inhibition of hypoxic induction of NF-
 

 
B in HIF-1
 

 
 knockout murine neutrophils suggests that
HIF-1
 

 
-dependent regulation of the NF-
 

 
B pathway medi-
ates the survival response observed. Furthermore, we identi-
fied macrophage inflammatory protein-1
 

 
 
 
(MIP-1
 

 
) as a
novel hypoxia-stimulated granulocyte survival factor, which
provides alternative and indirect facilitation of the direct hy-
poxic survival response.
Figure 1. Hypoxia inhibits constitutive neutrophil apoptosis.
(A) Apoptosis. After in vitro culture of human peripheral blood neutrophils 
for 20 h, cells were assessed for apoptosis by morphology (open bars) or 
FACS analysis of AV/PI staining (shaded bars). Results represent mean  
SEM (n  3), *, P  0.05 compared with normoxic controls. (B) Caspase 3 
activity. At the indicated times, caspase 3 activity (arbitrary units) was 
measured in neutrophil whole cell lysates after culture under different ox-
ygen tensions. Results represent mean  SEM (n  4); *, P  0.05 com-
pared with time-matched normoxic controls. (C) Electron microscopy of 
neutrophil apoptosis. Electron microscopy appearance of neutrophils aged 
for 20 h in vitro displaying progressive changes associated with apoptosis; 
this progression was inhibited in cells incubated under hypoxic or anoxic 
conditions.
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RESULTS
Hypoxia inhibits neutrophil apoptosis
 
Human peripheral blood neutrophils after 20 h in culture
displayed constitutive levels of apoptosis matching those pre-
viously reported (25). This was confirmed using both mor-
phological analysis and FACS quantification of AV and PI
staining (Fig. 1 A). This level of apoptosis was maintained
with culture at 10 kPa, but significantly inhibited when cells
were cultured under either anoxic (0 kPa) or hypoxic (3
kPa) conditions. Using a colorimetric substrate reaction, cas-
pase 3 activity in whole cell lysates was also significantly in-
hibited at 20 h under reduced oxygen tensions (Fig. 1 B).
Concurrent electron microscopy analysis of neutrophils age-
ing in vitro revealed classic appearance and progression of
apoptosis (Fig. 1 C) with early loss of euchromatin hetero-
chromatin differentiation followed by later changes of nu-
clear condensation and capping. In low oxygen tensions, the
cells appeared either normal or showed only minor changes
in euchromatin/heterochromatin differentiation compared with
cells cultured under normoxic conditions (percent cells with
nuclear condensation and capping at 20 h: 53% normoxia
compared with 16% hypoxia).
 
Hypoxic survival of neutrophils is PI3-kinase independent
 
Supernatants obtained from neutrophils cultured at reduced
oxygen tensions had a survival effect (assessed at 20 h) on
freshly isolated cells. This transferable survival effect was time
dependent, unrelated to the oxygen tension of the superna-
tants because they were reoxygenated before use, and was
only observed in supernatants harvested after 12 h of hypoxic
incubation (Fig. 2, A and B). Furthermore, there was no sta-
bilization of HIF-1
 

 
 protein in freshly isolated neutrophils
cultured in supernatants obtained from neutrophils incubated
under hypoxia. 10 
 

 
M LY294002, which we have previously
demonstrated to cause a selective inhibition of neutrophil
PI3-kinase activity (26, 27), fully inhibited the supernatant-
induced survival (Fig. 2 B). In marked contrast, hypoxia-
mediated neutrophil survival was unmodified by 10 
 

 
M
LY294002 or 100 nM wortmannin (Fig. 2 C). These data in-
dicate that although hypoxia causes the release of a soluble
factor with the capacity to operate in an autocrine survival
manner, this does not account for the direct hypoxia-medi-
ated survival effect, which is PI3-kinase independent.
 
MIP-1
 

 
 is a novel hypoxia-stimulated granulocyte 
survival factor
 
Pretreatment of hypoxic supernatants with trypsin (1:250
[wt/vol]) (at a concentration that blocked GM-CSF [100
ng/ml]–mediated survival) completely abrogated the survival
effect of the supernatants obtained from hypoxic neutrophils
(Fig. 3 A). However, this survival effect was not modified by
heat inactivation at 56
 

 
C (Fig. 3 B), which is characteristic of
chemokines. Luminex analysis of supernatants subsequently
identified a significant time-dependent increase in secreted
MIP-1
 

 
 after hypoxic stimulation (not depicted), a finding
which was independently verified by ELISA (Fig. 3 C). No
increase in supernatant levels of the known neutrophil sur-
vival cytokines IL-8, IL-6, IL-1
 

 
, GM-CSF, TNF
 

 
, or mi-
gration inhibitory factor
 
 
 
(MIF), was detected after hypoxic
stimulation. Critically, preincubation of the hypoxia-gener-
ated supernatants with a specific MIP-1
 

 
 neutralizing anti-
body at a concentration that blocked ELISA detection of
MIP-1
 

 
 in hypoxic supernatants (100 
 

 
g/ml; Fig. 3 D)
completely blocked the survival effect.
 
Competitive inhibition of hydroxylase enzymes mimics 
hypoxic survival
 
Using a series of immunoprecipitation and inhibitor assays,
we looked for the presence of classical oxygen-sensing regu-
lators in human neutrophils. FIH was demonstrated in neu-
trophil lysates under all oxygen tensions and in the presence
of both the iron chelator DFO (1 mM) and the competitive
hydroxylase inhibitor dimethyloxaloylglycine (DMOG; 1
mM) (Fig. 4 A). DMOG was able to fully mimic the inhibi-
tion of neutrophil apoptosis observed at low oxygen tensions
(8 
 
 
 
3% apoptosis 20 h, 1 mM DMOG, P
 
 
 
 
 
0.05) (Fig. 4
Figure 2. Hypoxia induces the release of a PI3-kinase–dependent 
survival factor. (A) Survival factor secretion. Conditioned medium (CM) 
obtained from normoxic, hypoxic, or anoxic neutrophils was transferred to 
freshly isolated cells with subsequent analysis of apoptosis at 6 h (open 
bars) and 20 h (shaded bars). Results represent mean  SEM (n  3); 
*, P  0.05 compared with medium (M)-only controls. (B) Survival effect 
of CM is PI3-kinase dependent. Neutrophils were cultured with CM in the 
presence of the PI3-kinase inhibitor LY294002 (shaded bars), and apopto-
sis was assessed by morphology. Results represent mean  SEM (n  3); 
*, P  0.05 compared with medium (M)-only controls. (C) PI3-kinase–
independent hypoxic survival. Neutrophils were cultured in normoxia 
(open bars), hypoxia (shaded bars), or anoxia (hatched bars) in the presence 
of PI3-kinase inhibitors LY294002 or wortmannin or the survival cytokine 
GM-CSF, and apoptosis was assessed morphologically. Results represent 
mean  SEM (n  3); *, P  0.05 compared with normoxic control.
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B). Moreover, DMOG was unable to enhance the survival
effect of hypoxia and was effective at 100 
 

 
M, which com-
pares with maximal effects in tissue culture cells at 1 mM
(28, 29). Accumulation of HIF-1
 

 
 was observed both in
hypoxia and anoxia, and after culture with 1 mM DFO or 1
mM DMOG (Fig. 4 C). Of note, we were unable to detect
HIF-2
 

 
 (unpublished data), supporting our previous work
describing a lack of HIF-2
 

 
 RNA in neutrophils (24).
 
HIF-1
 

 
 regulates neutrophil survival at reduced 
oxygen tensions
 
To establish a more direct link between HIF-1
 

 
 and the
regulation of neutrophil apoptosis, we used a recently estab-
Figure 3. MIP-1 is a novel hypoxia-stimulated granulocyte survival 
factor. (A) Trypsin sensitivity. Freshly isolated cells were incubated in condi-
tioned medium (CM) obtained from normoxic neutrophils (control) or hypoxic 
neutrophils (hypoxia CM). These media were either untreated or treated for 
2 h with trypsin (1:250 wt/vol), followed by treatment with soya bean 
trypsin inhibitor (SBTI) or SBTI alone. The effects of trypsin on GM-CSF 
(100 ng/ml)–mediated neutrophil survival was examined in parallel. Apopto-
sis was subsequently analyzed at 20 h, and the results represent mean  SD 
(n  2); *, P  0.05 compared with matched trypsin-untreated conditions. 
(B) Heat insensitivity. Neutrophils were incubated with CM obtained from 
normoxic neutrophils (control), hypoxic neutrophils (hypoxia CM), or GM-CSF 
(100 ng/ml)–supplemented monofeed that was previously heated to 56C 
for 45 min. Apoptosis was subsequently analyzed by morphology at 20 h. 
Results represent mean  SEM (n  3). (C) MIP-1 secretion. MIP-1 
released into the CM obtained from normoxic (open bar), hypoxic (shaded 
bar), or anoxic (hatched bar) neutrophils or unconditioned medium (M) was 
measured by ELISA at 6 and 20 h. Results represent mean  SEM (n  3); *, 
P  0.05 compared with time-matched normoxic CM. (D) MIP-1 antibody 
blocks transferable survival. CM obtained from normoxic or hypoxic neutro-
phils or medium alone (M) was incubated in the presence (	) or absence 
(
) of 100 g/ml anti–MIP-1 antibody or 100 g/ml of total goat IgG iso-
type control for 30 min at room temperature, before being added to freshly 
isolated cells. GM-CSF (100 ng/ml) in the presence (	) or absence (
) of 
anti–MIP-1 or IgG controls were run in parallel, and apoptosis was assessed 
by 20-h morphology. Results represent mean  SD (n  2); *, P  0.05 
compared with matched MIP-1 antibody–untreated conditions.
Figure 4. Competitive inhibition of hydroxylase enzymes mimics hy-
poxic survival. (A) Human neutrophils possess FIH. After culture, under 
each oxygen tension or in the presence of either the iron chelator DFO or 
the hydroxylase inhibitor DMOG, whole cell lysates were prepared from pe-
ripheral blood neutrophils; immunoprecipitation was performed with an 
antibody to FIH and separated on SDS-PAGE. Control lysates were also pre-
pared from pulmonary artery smooth muscle cells and run directly on SDS-
PAGE without immunoprecipitation. (B) DMOG inhibits human neutrophil 
apoptosis. Neutrophils were cultured with increasing concentrations of 
DMOG under normoxia (open bars), hypoxia (shaded bars), and anoxia 
(hatched bars), and apoptosis was assessed by morphology. Results repre-
sent mean  SEM (n  3); *, P  0.05 compared with normoxic control. (C) 
Hypoxia stabilizes HIF-1 in human neutrophils. Lysates were prepared 
from neutrophils after culture in hypoxia, anoxia, normoxia or in the pres-
ence of DMOG or DFO. Lysates were immunoprecipitated with an antibody 
to HIF-1 and separated by SDS-PAGE. Both blots are representative of n  3.
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lished murine HIF-1 conditional knockout model (18).
Compared with wild-type controls, bone marrow–derived
neutrophils obtained from lysMcre HIF-1–targeted animals
demonstrated a marked increase in ghost cells and cells dis-
playing pyknotic nuclei and nuclear fragmentation after a
20-h culture in anoxia (P  0.05; Fig. 5 A). This was
matched by a decrease in neutrophil survival, as indicated by
FACS-quantified PI staining (Fig. 5 B). The lack of HIF-1
did not, however, influence the extent of apoptosis observed
under normoxic conditions (20-h normoxic survival: for
knockout animals, 76  5%; and for wild-type animals, 77 
5%) (Fig. 5 C). In contrast to human and murine peripheral
blood neutrophils, a significant annexin V–negative and
PI-positive population of cells were evident in our cultured
murine bone marrow–derived cells. This is common to many
studies using immature bone marrow–derived neutrophils
(30). Together, these results demonstrate that the presence of
HIF-1 is essential for murine neutrophils to survive in an
oxygen deficient environment.
Hypoxia regulates neutrophil transcript abundance
To identify potential downstream targets of HIF-1 in hu-
man neutrophils, we performed a series of gene array exper-
iments looking at changes in transcript abundance with
reduced oxygen tension. Radioactively labeled complex
cDNA probes were prepared from neutrophil RNA and hy-
bridized to a 988–cDNA sequence verified the apoptosis-
targeted nylon filter gene array generated in our laboratories
(31). After an initial culture period of 3 h, we saw no detect-
able changes in the relative transcript abundance among nor-
moxic, hypoxic, or anoxic conditions (unpublished data).
However, with a more prolonged culture (6 h), glyceralde-
hyde 3-phosphate dehydrogenase (G3PDH), MIF, triose-
phosphate isomerse-1, and NF-B (p65) showed a twofold
or more relative increase in expression in both hypoxia and
anoxia compared with normoxia (Fig. 6 A). This was shown
to be significant by Bayesian t tests (Fig. 6 A, table). We sub-
sequently confirmed the changes for G3PDH, MIF, and
NF-B (p65) using TaqMan quantitative PCR; in these ex-
periments, the expression of each transcript was estimated
relative to granulocyte-specific CSF3R identified on the
gene array as a nonchanging, nonoxygen-regulated endoge-
nous control (Fig. 6 B). The G3PDH response offers an ap-
propriate internal positive control in these experiments be-
cause of its well-characterized regulation by oxygen tension
(32) and, more specifically, HIF (33, 34).
NF-B activity is required for hypoxic survival
After the identification of NF-B p65 as a hypoxia-regulated
transcript, we examined the effects of hypoxia on total NF-
B p65 expression relative to IkB expression, and overall
effects of hypoxia on NF-B activity. At early time points
Figure 5. HIF-1 regulates neutrophil survival at reduced oxygen 
tensions. (A) Apoptotic morphology. Murine bone marrow–derived neu-
trophils were cultured for 20 h under normoxic or anoxic conditions. 
Apoptosis was assessed by morphology. (B) Annexin V/ Pi. Identical sets of 
cells were analyzed by FACS for AV/PI staining. (C) Reduced survival in HIF-
1 knockout cells under anoxic conditions. Percent survival was calculated 
after AV/PI staining. Results represent mean  SEM (n  3); *, P  0.05 
compared with HIF-1 	/	 control.
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(3–12 h), we observe progressive and near complete loss of
constitutive NF-B expression with a parallel loss in IB
(Fig. 7, A and B). In normoxia, this early decline remained
unchecked and there was no subsequent rebound in detect-
able NF-B or IB protein levels. However, at reduced
oxygen tensions, we observed a later (12–20 h) recovery in
NF-B p65 and IB levels, which followed the early hy-
poxia-driven increase in p65 transcript abundance. NF-B
activity assays at these times confirmed the capacity of the
newly expressed NF-B to bind appropriate oligonucleotide
sequences (Fig. 7 C). Moreover culture of neutrophils in re-
duced oxygen tensions with the structurally and mechanisti-
cally discrete NF-B inhibitors gliotoxin and parthenolide,
at concentrations that are specific and do not modify consti-
tutive apoptotic rates (23), resulted in the ablation of the hy-
poxic survival effect (Fig. 8, A and B). These inhibitors also
attenuated the hypoxic survival effect if added 12 h into the
incubation period (unpublished data).
We have previously demonstrated that NF-B is a key
survival transcription factor in cytokine-stimulated neutro-
phils (23) and, hence, the hypoxic-driven stabilization and
activation of NF-B provides a direct link between oxygen
deprivation and a recognized antiapoptotic pathway. To ad-
dress more specifically the link between HIF-1 and NF-
B, we performed a series of real-time PCR experiments
looking at changes in transcript abundance in HIF-1 wild-
type and knockout murine neutrophils. After 12 h in cul-
ture, we saw a significant hypoxic induction of NF-B, and
IKK, an alternative regulator of NF-B, in addition to
PGK, a known HIF-1–regulated glycolytic enzyme (Fig. 8
C). This induction was significantly abrogated in the HIF-
1 knockout mice and implicates a HIF-1–dependent reg-
ulation of both NF-B and IKK.
Figure 6. Hypoxia regulates human neutrophil transcript abundance. 
(A) Regulation of transcript abundance. Log (base 10) mean signal intensi-
ties were calculated and compared from array filters prepared using RNA 
from human peripheral blood neutrophils cultured under the oxygen 
tensions shown. Points represent the mean (SEM bars) of n  3 experi-
ments; each gene is presented in duplicate. Outer lines represent a two-
fold change between conditions. All significant transcripts are individually 
named. The table shows the statistical analysis of the gene array data. 
Cyber-T tests were performed to calculate the Bayesian p values shown. 
(B) TaqMan confirmation. Array findings (open bars) were validated for 
hypoxia (H), and anoxia (A) by TaqMan analysis of duplicate RNA samples 
(shaded bars) using the nonchanging endogenous control CSF3R (granu-
locytes). Data represent mean  SEM of n  3 experiments.
Figure 7. Hypoxia stimulates the reexpression of NF-B protein and 
maintains activity. (A) Reexpression of IB and NF-B protein with pro-
longed oxygen deprivation. Human neutrophil lysates were prepared after 
culture in normoxia  TNF, hypoxia, or anoxia for 10 min–20 h, and the 
total protein was measured by Western blot. Blots shown are representa-
tive of n  3–9 experiments. (B) OD quantification of Western blots. Opti-
cal densities of IB and NF-B Western blots were quantified for nor-
moxia (open bars), hypoxia (shaded bars), anoxia (hatched bars) and TNF- 
(striped bars) using Scion corporation software and normalized to nor-
moxia 10 min (10 min-6 h blots) or normoxia 1 h (1–20 h blots). Data 
represent mean  SEM (n  4). (C) Decreased p50 and p65 activity with 
prolonged normoxia. p50 or p65 DNA binding activity was measured by 
ELISA in normoxic (open bars), hypoxic (shaded bars) or anoxic (hatched 
bars) neutrophil lysates at the time points shown. Data represent mean  
SEM for n  3 experiments, * P  0.05 compared with normoxia 1 h.
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DISCUSSION
Our results describe for the first time the presence of the
functionally active HIF-1 hydroxylase oxygen-sensing path-
way in human peripheral blood neutrophils. The absence of
HIF-2 expression demonstrates the differential expression
of key members of this pathway between various myeloid
lineage cells (35, 36). Because of the nonredundant function
between different HIF  subunits (16), this expression pat-
tern may have a significant impact on how granulocytes sense
and respond to changes in oxygenation.
The ability of hypoxia to regulate apoptotic thresholds is
a cell-specific phenomenon. Hence, in neuronal cells, ade-
nocarcinoma HT 29 cells, certain oncogenically transformed
cells and cardiac myocytes hypoxia clearly acts to induce
rather than inhibit apoptotic cell death (37, 38). This may
reflect the different abilities of cells to adapt to anaerobic
metabolism. In neutrophils, we show that the inhibition of
apoptosis by hypoxia is accompanied by a time-dependent
induction of transcripts for G3PDH and triosephosphate iso-
merse-1. The induction of these key glycolytic enzymes
provides a mechanism for the continued generation of ATP,
which is an essential requirement for neutrophil functional
responses to inflammatory stimuli (39). With respect to
GAPDH, this also provides indirect evidence for HIF-1
transcriptional activation caused by the presence of func-
tional hypoxia-responsive elements within the GAPDH pro-
moter region (33, 34).
Initial work in the myeloid-targeted HIF-1 knockout
mice has provided a further link between in vivo inflamma-
tory responses and HIF-1–dependent maintenance of intra-
cellular energy homeostasis (18). In addition to the ATP-depen-
dent loss of function and diminished migratory potential, our
data suggest that a second mechanism, namely decreased
neutrophil survival, may also contribute to the impaired in-
flammatory response observed in these animals. Hence, we
show a marked reduction in cell survival after anoxic chal-
lenge in murine bone marrow–derived neutrophils lacking
HIF-1. Because we see no modification of constitutive
apoptosis in the HIF
/
 cells, the reduced survival would
only be unmasked at sites of low oxygenation. This would
be consistent with the normal total neutrophil count, but di-
minished inflammation seen in the HIF-1 myeloid-tar-
Figure 8. NF-B activity is required for hypoxic neutrophil survival 
and dependent on HIF-1 expression. (A) Inhibition of hypoxic survival 
with gliotoxin. Neutrophils were incubated under the oxygen tensions 
shown in the presence or absence of gliotoxin for 20 h. Apoptosis was 
assessed by morphology. Results represent mean  SEM of n  3 experi-
ments; *, P  0.05 compared with oxygen-matched medium only con-
trols. (B) Inhibition of hypoxic survival with parthenolide. Neutrophils were 
incubated in normoxia (open bars) or hypoxia (shaded bars) in the presence 
or absence of parthenolide for 20 h. Apoptosis was assessed by morphol-
ogy. Results represent mean  SEM of n  3 experiments; *, P  0.05 
compared with oxygen-matched medium-only controls. (C) Hypoxic in-
duction of PGK, NF-B, and IKK message is inhibited in HIF-1 knockout 
mice. TaqMan analysis of PGK, NF-B, IB, and IKK transcript abun-
dance relative to -actin was performed on cDNA isolated from bone 
marrow–derived murine neutrophils from wild-type (open bars) and 
HIF-1 knockout mice (shaded bars) after culture in normoxia and anoxia. 
Data represent mean fold changes  SD from pooled cDNA from 16 mice 
in two independent experiments; *, P  0.05 and #, P  0.005 compared 
with matched wild-type controls.
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geted knockout mice and the exaggerated inflammatory
responses described in the VHL knockout animals (18). Al-
though murine bone marrow–derived neutrophils display
different AV/PI staining properties and lower 20-h levels of
constitutive cell death, the above data clearly support a role
for HIF-1 the regulation of human neutrophil survival un-
der hypoxic conditions. This conclusion is further supported
by preliminary data obtained in patients with von Hippel-
Lindau disease where enhanced survival of peripheral blood
neutrophils is observed (unpublished data). Contaminating
bone marrow monocytes are unlikely to influence these
observations because human peripheral blood monocyte de-
pletion does not modify the rate of apoptosis under either
normoxia or hypoxia (40). The involvement of a hydroxyl-
ase-dependent pathway is confirmed in human granulocytes
by the antiapoptotic properties of the competitive hydroxyl-
ase inhibitor DMOG.
The mechanism by which HIF regulates neutrophil
apoptosis remains to be fully characterised. However, the in-
hibition of hypoxic survival by gliotoxin and parthenolide
implies that NF-B is an important downstream effector of
the HIF-1–dependent response. Temporally, this is sup-
ported by the early stabilization of HIF-1 that is followed
by the increase at 6 h in p65 transcript abundance and subse-
quent (12–20 h) reexpression of NF-B and the persistence
in NF-B p65 and p50 DNA binding activity. The regula-
tion of NF-B by hypoxia is already described for different
cell types, including J774.1 murine macrophage and RF/6A
retinal lines (41, 42), yet interactions between HIF and NF-
B are poorly understood. Studies looking at the nonhy-
poxic induction of HIF have shown a number of indirect
links between the HIF and NF-B transcription pathways.
In neuronal cells, a HIF-dependent up-regulation of eryth-
ropoietin has been described to prevent excitotoxin-induced
apoptosis through Jak2 NF-B cross-talk (43), whereas in
human embryonic kidney cells, TNF stimulates the accu-
mulation of ubiquitinated HIF via an NF-B–dependent
pathway (44). Furthermore, the essential modulator of
NF-B NEMO/IKK has recently been shown to be a bind-
ing partner for HIF-2 (Peet, D.J., and C. Braken, personal
communication). To date, no direct association between
HIF and NF-B has been reported after stimulation of cells
with hypoxia. Using a series of real-time PCR reactions in
HIF-1 knockout and wild-type neutrophils, we show for
the first time the hypoxic induction of NF-B transcription
to be dependent on the presence of HIF-1. Moreover, we
show a HIF-1–dependent up-regulation of the alternative
NF-B regulator IKK. IKK is recognized both to facili-
tate NF-B transcriptional activity through the alternative
pathway and itself be critical for the histone phosphorylation
required for the activation of NF-B–directed gene expres-
sion (45). Thus HIF-1 not only facilitates an increase in
NF-B message but also facilitates the pathways required for
enhanced transcriptional activity.
A key regulator of the NF-B pathway in neutrophils is
IB. After neutrophil stimulation with pro-inflammatory
molecules, IB is degraded resulting in unopposed NF-B
activity (46, 47). Conversely, the nuclear localization of IB
results in increased neutrophil apoptosis (48). Given the per-
sistent expression of IB protein with prolonged hypoxic
culture and the lack of HIF-1–dependent changes in mu-
rine transcript abundance, it is unlikely that HIF mediates
the stimulation of NF-B through the transcriptional inhibi-
tion of IB, although an indirect regulation of IB nu-
clear trafficking remains possible.
It is important to note that the inhibition of the PI3-
kinase pathway has no effect on the direct inhibition of neu-
trophil apoptosis by hypoxia. This is in direct contrast to the
survival effect of the supernatants derived from hypoxically
cultured cells. Using heat inactivation and trypsin digestion,
we first identify this factor to be a protein and possible cyto-
kine. Luminex analysis, ELISA, and blocking antibody exper-
iments subsequently support the identity of this cytokine as
MIP-1. Although the identification of MIP-1 as an oxy-
gen-sensitive granulocyte survival factor is novel, MIP-1 is
recognized to be up-regulated in Bacillus Calmette-Guerin–
stimulated neutrophils along with MCP-1 and MIP-1 (49).
Interestingly, these cells were also noted to have diminished
rates of apoptosis. In addition, MIP-1 secretion by murine
alveolar macrophages has been shown to be oxygen sensitive
(50). These studies further support the role of MIP-1 as a
novel hypoxia-stimulated granulocyte survival factor. In par-
allel, gene array analysis of human neutrophils identified the
hypoxic induction of MIF mRNA. MIF has previously been
described both as a neutrophil survival factor through its inhi-
bition of Bax/Bid cleavage and caspase 3 activity (51) and as a
hypoxia-regulated cytokine (52). However, we saw no in-
duction of MIF protein release into the culture media of
hypoxia-treated neutrophils. Although this does not exclude
an intracellular up-regulation of MIF protein and the subse-
quent down-regulation of Bax–Bid pathways, this does ex-
clude MIF as a transferable survival factor in our system.
In summary, we have revealed that the hypoxic inhibition
of neutrophil apoptosis is regulated by the HIF-1 hydroxyl-
ase oxygen-sensing pathway and NF-B reexpression, and in-
directly regulated by the release of the novel survival factor
MIP-1. Although we have identified the transcriptional and
functional activation of NF-B after hypoxia and the HIF-
1–dependent regulation of NF-B and I transcript, the
precise mechanism of this interaction remains to be eluci-
dated. HIF-1 would appear to be the critical upstream regu-
lator of this hypoxic survival pathway because deletion of
HIF-1 in murine neutrophils results in both a reduction in
NF-B and I message and anoxia-stimulated cell death.
MATERIALS AND METHODS
Isolation and culture of peripheral blood neutrophils from healthy
human volunteers. Neutrophils were purified by dextran sedimentation
and discontinuous plasma-Percoll gradients (25). Purified cells were resus-
pended at 5  106 cells/ml in IMDM supplemented with 10% autologous
serum and 50 U/ml streptomycin and penicillin. Cells were cultured in the
presence or absence of 1 mM DFO, 1 mM DMOG (unless otherwise
stated; a gift from C. Pugh, University of Oxford, Oxford, UK), 200 U/ml
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TNF, 100 ng/ml GM-CSF, 100 g/ml anti–human MIP-1, 100 g/ml
of total goat IgG, 1:250 (wt/vol) trypsin, or 1:250 (wt/vol) soya bean
trypsin inhibitor in normoxic (19 kPa), hypoxic (3 kPa) or anoxic (0 kPa)
environments. Normoxia was controlled by using a humidified 5% CO2/air
incubator, and hypoxia, by pregasing Dulbecco’s medium for 30 min in a
sealed hypoxic work station with 5% CO2/balance N2 gas mix and subse-
quent culture in a humidified hypoxic (CO2/N2) incubator. Anoxia was
maintained with a MACS500 Don Whitley catalyst–dependent anaerobic
incubator using 5% CO2/10% H2/balance N2 gas mix. Supernatants were
heat inactivated by warming to 56C for 45 min. Trypsin inactivation was
performed with a 2-h incubation with trypsin that was followed by the ad-
dition of an equimolar amount of soya bean trypsin inhibitor. All other in-
hibitor experiments were performed with a 30-min preincubation step.
Conditional knockouts and harvesting of bone marrow–derived
neutrophils.  Targeted myeloid deletions of HIF-1 were created via
crosses into a background of lysozyme M–driven cre (lysMcre) expression
(18). This resulted in an approximate 75% HIF-1 deletion rate in neutro-
phils (18). Mice were killed by CO2 asphyxia and bone marrow-derived
neutrophils were harvested from knockout and cre wild-type animals using
discontinuous 82, 62, and 51% HBSS-Percoll gradients. Cell purity, assessed
using air-dried cytospins, was routinely above 70%. Cells were cultured
as for human cells, replacing autologous serum with 10% FBS. Mice
were handled according to protocols approved by University of California
San Diego Animal Care Program, which follows the National Institutes of
Health guidelines for ethical animal treatment.
Apoptosis assays. Neutrophils were harvested at the time points indi-
cated, cytocentrifuged, fixed in methanol, and stained with May-Grünwald-
Giemsa (Merck Ltd.), and the morphology was examined by oil immersion
light microscopy (20). Apoptotic neutrophils were defined as those with
darkly stained pyknotic nuclei. Apoptosis was also assessed by flow cytometry
with fluorescein isocyanate–labeled recombinant human annexin V (AV)
and propidium iodide (PI) staining. Caspase 3 activity was measured by col-
orimetric substrate reaction (Calbiochem) according to the manufacturer’s
instructions. For electron microscopy analysis (CM 100 transmission electron
microscope; Philips) cells were fixed in glutaraldehyde and osmium tetrox-
ide, dehydrated in ethanol, and embedded in Spurr’s resin for sectioning.
Quantification of HIF-1, FIH, IB and NF-B protein. Whole
cell extracts were prepared by resuspending 25  106 neutrophils in 1 ml of
ice-cold hypotonic lysis buffer (10 mM Tris-HCl, pH 7.8, 1.5 mM EDTA,
10 mM KCl, 0.5 mM DTT, 1 mM sodium orthovanadate, 2 mM levami-
sole, 0.5 mM benzamidine, and 0.05% NP-40 and Complete protease in-
hibitor cocktail; Roche Applied Science); this was followed by sonication
(setting: 15, 15 s) (model Sanyo Soniprep-150; Fisson’s Instruments). HIF-
1 and FIH were immunoprecipitated with anti–HIF-1 mouse mono-
clonal (Ab1; Ab Cam) and anti-FIH rabbit polyclonal (a gift from D. Peet,
The University of Adelaide, Adelaide, Australia), respectively. Protein re-
covery for all samples was assessed by immunoblotting with primary anti-
bodies against HIF-1 (BD Transduction Laboratories), FIH (gift from D.
Peet), IB (New England Biolabs Cell Signaling Technology), and NF-
B p65 (Santa Cruz Biotechnology Inc.). All samples were protein cor-
rected, and equal loading confirmed by -actin expression.
Gene array analysis. Neutrophils (100  106/condition) were lysed with
2 ml TRIzol, and RNA was extracted using chloroform phase partitioning
and isopropanol. Samples were DNase digested (Ambion) and UV quanti-
fied, and the integrity was measured by 2100 Bioanalyser (Agilent Technol-
ogies). cDNA probes labeled with -[33P]dCTP were synthesized from
RNA by reverse transcription, purified, and hybridized to nylon gene array
filters. Each filter composed duplicate spots of 988 unique and sequence-
verified cDNAs with nonhomologous DNA controls (poly A, salmon
sperm DNA) and spiked Arabidopsis cDNA (reference 31; GEO database ac-
cession GSE968). Filters were read by phosphoimager, spots were quanti-
fied using Imagene 5.1, and after normalization for each blood donor, the
data were analyzed with Genespring software. All experiments were per-
formed in triplicate, each time neutrophils derived from a new blood donor
and RNA replicates hybridized once to the array were used.
TaqMan real-time PCR of human peripheral blood neutrophils.
cDNAs were synthesized from duplicate aliquots of RNA (as described in the
previous paragraph) using random hexamers and run at a final concentration
of 100 ng/l. Assays-on-Demand Gene expression TaqMan MGB 6FAM
dye-labeled products (Applied Biosystems) were used for macrophage; MIF,
GAPDH (G3PDH), NF-B (p65), and CD27-binding protein (SIVA) target
assays were performed according to the manufacturer’s (Applied Biosystems)
instructions. The reactions were quantified relative to the threshold cycle for
the highly expressed nonchanging endogenous control CSF3R (granulocyte).
Partial primer sequences were obtained from Applied Biosystems.
TaqMan real-time PCR of murine bone marrow neutrophils.
Neutrophils (5  106/condition) were lysed with 1 ml TRIzol and RNA
extracted using BCP phase partitioning and isopropanol. Samples were
DNase digested (Ambion), and cDNA was synthesized using random hex-
amers and run at a final concentration of 100 ng/ml. The following 6FAM
dye-labeled probes and primers were designed: for the murine NF-B
probe, 5-6[FAM]CGCTTTCGGAGGTGCTTTCGCAG[BHQ], primer
forward, 5 GGCGGCACGTTTTACTCTTT 3, and primer reverse,
5 CCGTCTCCAGGAGGTTAATGC 3; for the IB probe, 5-
6[FAM]TGCACTTGGCAATCATCCACGAAGA[BHQ] 3, primer for-
ward, 5 CGGAGGACGGAGACTCGTT 3, and primer reverse, 5 CTT-
CCATGGTCAGCGGCTT 3; for the IKK probe, 5-6[FAM]CGTGT-
TCTCAAGGAGCTGTTTGGTCACC[BHQ] 3, primer forward, 5
TGCACACCGTGCAGAGTCA 3, and primer reverse, 5 TGCTTG-
CAGCCCAACAACT 3; for the PGK primer forward, 5 CTGTGG-
TACTGAGAGCAGCAAGA 3, and primer reverse, 5 CAGGACCAT-
TCCAAACAATCTG 3; and for the -actin primer forward, 5
AGGCCCAGAGCAAGAGAGG 3, primer reverse: 5 TACATGGC-
TGGGGTGTTGAA 3. Afterwards they were run at 250 nM (probe) and
900 nM (forward/reverse primers) per reaction. Threshold cycles were
quantified relative to -actin.
NF-B activity assays. Whole cell lysates were prepared as described
earlier (Quantification of HIF-1...protein section) and NF-B p50 and
p65 activities were measured using the Active Motif TransAm NF-B Fam-
ily ELISA, with bound oligonucleotide containing the NF-B consensus
binding site, as recommended by the manufacturer (Active Motif Europe).
Cytokine analysis. Supernatants were collected at 6 and 20 h by centrifu-
gation, and MIP-1, IL-8, IL-6, IL-1, GM-CSF, TNF-, and MIF re-
leases were measured using duo set ELISA kits according to the manufac-
turer’s instructions (R&D Systems). Luminex analysis of supernatants was
performed by Rules-Based Medicine, INC.
Statistical analysis. Gene array data were analyzed for statistical signifi-
cance after normalization using a Bayesian prior modified t test (31). All
other data are expressed as mean  SEM, and significance determined by
one-way analysis of variance with a post-test Tukey of P  0.05.
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